文献速递艾滋病与性传播感染

抗逆转录病毒治疗HIV感染者大型队列中HIV相关神经认知障碍患病率近年下降及相关因素

Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIV.
PubMed 文献 · Clin Infect Dis · 2023-01-01

该横断面分析纳入2009至2020年间接受抗逆转录病毒治疗(ART)的HIV感染者1424例,按Frascati标准评估HIV相关神经认知障碍(HAND)。总体HAND患病率为24%,有认知主诉者(572/1424)为38%,高于无主诉者的15%。研究期间总体人群和有主诉者HAND患病率下降(P<0.001),无主诉者保持稳定(P=0.182)。

要点

  • 总体HAND患病率24%,有认知主诉者38%,高于无主诉者的15%。
  • 研究期间总体及有主诉者HAND患病率下降(P<0.001),无主诉者稳定(P=0.182)。
  • 高龄、低教育水平、较低当前CD4+ T细胞计数和HCV合并感染与HAND相关。

核心结论

  • 在主要为病毒学抑制的ART治疗HIV感染者大型队列中,观察到HAND患病率显著下降。
  • 除HIV和患者相关因素外,双药及基于INSTI的方案与HAND风险降低相关,且更近年份开始ART亦与风险降低相关,作者认为这可能提示新治疗策略因病毒学疗效更好和耐受性更佳而在HAND下降中发挥潜在作用。

研究设计与样本

  • 横断面分析,纳入2009至2020年间接受神经心理检查的ART治疗HIV感染者,检查采用12项测试组合评估5个不同领域。
  • HAND按Frascati标准分类,参与者根据是否报告认知主诉分为有主诉和无主诉,共纳入1424例HIV感染者,覆盖四个三年期。
  • 采用趋势卡方检验和多变量逻辑回归分析。

主要发现

  • 总体HAND患病率为24%;有主诉者(572/1424)为38%,高于无主诉者的15%。
  • 研究期间,总体人群HAND患病率下降(P<0.001),有主诉者亦下降(P<0.001);无主诉者保持稳定(P=0.182)。
  • 与HAND相关的因素包括年龄较大、教育水平较低、当前CD4+ T细胞计数较低和HCV合并感染。
  • 与未接受非核苷类逆转录酶抑制剂相比,接受双药和基于整合酶链转移抑制剂(INSTI)的方案与HAND风险降低相关,更近年份接受检测亦与风险降低相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: HIV-associated neurocognitive disorders (HAND) have been suggested as persistent even with effective antiretroviral therapy (ART). Aims were to evaluate HAND prevalence and associated factors, in a large cohort of people-with-HIV (PWH). METHODS: ART-treated PWH, underwent a neuropsychological examination through a battery of 12 tests exploring 5 different domains, between 2009 and 2020, were included in this cross-sectional analysis. HAND were classified according to Frascati's criteria. Participants were defined as complaining or not-complaining if a cognitive complaint was reported or not. Chi-square for trend and multivariable logistic regression were fitted. RESULTS: Overall, 1424 PWH were enrolled during four three-years periods. HAND prevalence was 24%; among complainers (572/1424), it was 38%, higher than among not-complainers (15%). Over the study period, a decreasing HAND prevalence was found in the entire population (P < 0.001) and in complaining (P < 0.001); in not-complaining it remained stable (P = 0.182). Factors associated with HAND were older age, lower educational level, lower current CD4+ T-cell count and HCV co-infection. Compared to nonnucleoside reverse transcriptase inhibitors, receiving dual and integrase strand transfer inhibitor (INSTI)-based therapies was associated with a decreased risk of HAND, as well as being tested in more recent years. CONCLUSIONS: In this large cohort of ART-treated PWH, mostly virologically suppressed, a remarkable decreasing HAND prevalence was observed. Besides HIV- and patient-related factors, the reduced risk of HAND found with dual and INSTI-based regimens along with a more recent ART initiation, could suggest a potential role of new treatment strategies in this decline, due to their greater virologic efficacy and better tolerability.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mastrorosa I, Pinnetti C, Brita AC, et al. Declining Prevalence of Human Immunodeficiency Virus (HIV)-Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy-Treated Individuals With HIV. Clin Infect Dis. 2023. PMID: 35982541. doi:10.1093/cid/ciac658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。